Primemd Stock Net Income
| PRMD Stock | USD 0.0005 0.00 0.00% |
As of the 5th of February, Primemd holds the Risk Adjusted Performance of 0.0996, coefficient of variation of 812.4, and Variance of 67.34. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Primemd, as well as the relationship between them. Please check Primemd standard deviation and maximum drawdown to decide if Primemd is priced some-what accurately, providing market reflects its current price of 5.0E-4 per share. As Primemd appears to be a penny stock we also advise to check out its information ratio numbers.
Primemd's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Primemd's valuation are provided below:Primemd does not presently have any trending fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Primemd |
Primemd 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Primemd's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Primemd.
| 11/07/2025 |
| 02/05/2026 |
If you would invest 0.00 in Primemd on November 7, 2025 and sell it all today you would earn a total of 0.00 from holding Primemd or generate 0.0% return on investment in Primemd over 90 days. Primemd Inc., together with its subsidiaries, is engaged in the purchase and development of residential and commercial r... More
Primemd Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Primemd's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Primemd upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.1152 | |||
| Maximum Drawdown | 66.67 |
Primemd Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Primemd's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Primemd's standard deviation. In reality, there are many statistical measures that can use Primemd historical prices to predict the future Primemd's volatility.| Risk Adjusted Performance | 0.0996 | |||
| Jensen Alpha | 0.9579 | |||
| Total Risk Alpha | 0.392 | |||
| Treynor Ratio | 1.29 |
Primemd February 5, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0996 | |||
| Market Risk Adjusted Performance | 1.3 | |||
| Mean Deviation | 1.99 | |||
| Coefficient Of Variation | 812.4 | |||
| Standard Deviation | 8.21 | |||
| Variance | 67.34 | |||
| Information Ratio | 0.1152 | |||
| Jensen Alpha | 0.9579 | |||
| Total Risk Alpha | 0.392 | |||
| Treynor Ratio | 1.29 | |||
| Maximum Drawdown | 66.67 | |||
| Skewness | 8.12 | |||
| Kurtosis | 66.0 |
Primemd Backtested Returns
Primemd is out of control given 3 months investment horizon. Primemd maintains Sharpe Ratio (i.e., Efficiency) of 0.13, which implies the firm had a 0.13 % return per unit of risk over the last 3 months. We have collected data for sixteen different technical indicators, which can help you to evaluate if expected returns of 1.08% are justified by taking the suggested risk. Use Primemd Variance of 67.34, coefficient of variation of 812.4, and Risk Adjusted Performance of 0.0996 to evaluate company specific risk that cannot be diversified away. Primemd holds a performance score of 10 on a scale of zero to a hundred. The company holds a Beta of 0.77, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Primemd's returns are expected to increase less than the market. However, during the bear market, the loss of holding Primemd is expected to be smaller as well. Use Primemd standard deviation, maximum drawdown, as well as the relationship between the Maximum Drawdown and day median price , to analyze future returns on Primemd.
Auto-correlation | -92,233,720,368,547,760 |
Near perfect reversele predictability
Primemd has near perfect reversele predictability. Overlapping area represents the amount of predictability between Primemd time series from 7th of November 2025 to 22nd of December 2025 and 22nd of December 2025 to 5th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Primemd price movement. The serial correlation of -9.223372036854776E16 indicates that 9.223372036854776E16% of current Primemd price fluctuation can be explain by its past prices.
| Correlation Coefficient | -92233.7 T | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Primemd reported net income of (101,123). This is 100.03% lower than that of the Healthcare sector and significantly lower than that of the Medical Care Facilities industry. The net income for all United States stocks is 100.02% higher than that of the company.
Primemd Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Primemd's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Primemd could also be used in its relative valuation, which is a method of valuing Primemd by comparing valuation metrics of similar companies.Primemd is currently under evaluation in net income category among its peers.
Primemd Fundamentals
| Return On Equity | -0.0685 | |||
| Return On Asset | -0.0182 | |||
| Profit Margin | (1.17) % | |||
| Operating Margin | (0.58) % | |||
| Current Valuation | 76.82 K | |||
| Price To Book | 0.07 X | |||
| Price To Sales | 0.47 X | |||
| Revenue | 69.98 K | |||
| Gross Profit | 67.8 K | |||
| EBITDA | (36.75 K) | |||
| Net Income | (101.12 K) | |||
| Cash And Equivalents | 435.5 K | |||
| Cash Per Share | 0.14 X | |||
| Current Ratio | 1.20 X | |||
| Book Value Per Share | 0.38 X | |||
| Cash Flow From Operations | (90.82 K) | |||
| Earnings Per Share | (0.03) X | |||
| Beta | -4.28 | |||
| Market Capitalization | 76.82 K |
About Primemd Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Primemd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Primemd using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Primemd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Primemd Pink Sheet
Primemd financial ratios help investors to determine whether Primemd Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Primemd with respect to the benefits of owning Primemd security.